Schleswig-Holstein Excellence-Chairs In 2015 Kiel University and the University of Lübeck called for nominations for eight Schleswig-Holstein Excellence Chairs in a joint competition. In the context o

Clinician Scientists The promotion of clinician scientists plays a central role in the Cluster of Excellence PMI. There is a deficit throughout Germany of these specialists who research at an internat

Active agent developed in the Cluster of Excellence PMI is successful in clinical study Placebo-controlled phase II study confirmed efficacy of olamkicept in patients with ulcerative colitis . Ulcerat

TI-2: Integrative Immmunogenetics and Cellular Approaches toward Developing an Antigen-Specific Therapy Coordinators: P. Bacher (CAU), Andre Franke (CAU), A. Scheffold (CAU), T. Lenz (MPI) The members

CD-2: Tryptophan Metabolism and Inflammation Coordinators: M. Laudes (CAU), S. Krauss-Etschmann (RCB, CAU), S. Nikolaus (CAU) In CD-2, clinical feasibility studies are prepared and carried out with th

Genotoxic E. coli “caught in the act” of transforming primary colon cells A research team led by Kiel senior professor and member  of PMI Thomas F. Meyer reveals transformation of colon organoids in v

Kiel genome sequencing center transitions to second round of funding The DFG is providing further funding for the Competence Centre for Genomic Analysis Kiel (CCGA Kiel) at Kiel University until 2023.

COVID-19: mRNA vaccination is safe and effective even with chronic inflammatory diseases For the first time, members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" have been

Research of the Cluster of Excellence PMI Understanding and healing inflammation At the Cluster of Excellence PMI, excellent scientists collaborate on an interdisciplinary basis across subject boundar

About the Cluster of Excellence PMI More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Clus